The current financial score of Inspire Medical Systems Inc is 8.50. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 200.58M, representing a year-over-year decrease of 7.60%, while its net profit experienced a year-over-year decrease of 108.74%.
The current valuation score of Inspire Medical Systems Inc is 8.01. Its current P/E ratio is 16.32, which is 6230.18% below the recent high of 1033.03 and 3006.95% above the recent low of -474.39.
The current earnings forecast score of Inspire Medical Systems Inc is 6.44. The average price target is 68.19, with a high of 180.00 and a low of 40.00.
The current price momentum score of Inspire Medical Systems Inc is 5.19. Currently, the stock price is trading between the resistance level at 79.49 and the support level at 62.00, making it suitable for range-bound swing trading.
The current institutional shareholding score of Inspire Medical Systems Inc is 10.00. The latest institutional shareholding proportion is 121.22%, representing a quarter-over-quarter increase of 4.27%. The largest institutional shareholder is James Simons, holding a total of 426.00K shares, representing 0.03% of shares outstanding, with 43.07% decrease in holdings.
The current risk assessment score of Inspire Medical Systems Inc is 4.99. The company's beta value is 0.76. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.